| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |